Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company ...

Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are covering the company, MarketBeat reports.

March 31, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...

Rani Therapeutics Hldgs RANI will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for ...

Cash, cash equivalents and marketable securities as of December 31, 2024 totaled $27.6M, compared to $48.5M for the year ended December 31, ...

March 31, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of ...

Despite a significant decrease in cash reserves, Rani Therapeutics Holdings Inc (RANI) focuses on advancing its promising RaniPill technology and strategic programs.

Please go ahead. Thank you, Operator. Please turn to Slide 2. Joining us on the call today from Rani Therapeutics are Chief Executive Officer, Talat Imran; and Chief Financial Officer, Svai Sanford.

March 31, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial ...